2010
DOI: 10.1371/journal.pone.0009137
|View full text |Cite
|
Sign up to set email alerts
|

ENU Mutagenesis Reveals a Novel Phenotype of Reduced Limb Strength in Mice Lacking Fibrillin 2

Abstract: BackgroundFibrillins 1 (FBN1) and 2 (FBN2) are components of microfibrils, microfilaments that are present in many connective tissues, either alone or in association with elastin. Marfan's syndrome and congenital contractural arachnodactyly (CCA) result from dominant mutations in the genes FBN1 and FBN2 respectively. Patients with both conditions often present with specific muscle atrophy or weakness, yet this has not been reported in the mouse models. In the case of Fbn1, this is due to perinatal lethality of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
23
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(25 citation statements)
references
References 27 publications
2
23
0
Order By: Relevance
“…This test was performed using a strength gauge with an attached mouse specific square wire grid (6 cm × 6 cm; Bioseb, France), similar to Miller et al (2010). Mice were carefully placed in front of the wire grid and allowed to grab hold with both forepaws.…”
Section: Methodsmentioning
confidence: 99%
“…This test was performed using a strength gauge with an attached mouse specific square wire grid (6 cm × 6 cm; Bioseb, France), similar to Miller et al (2010). Mice were carefully placed in front of the wire grid and allowed to grab hold with both forepaws.…”
Section: Methodsmentioning
confidence: 99%
“…In animal models, Fbn2 null mice experienced complications in the development of the mineralized bone and chondrocyte matrix. Rather than longer bones, they showed shorter bones with syndactyly (thought to be due to defective mesenchyme differentiation and failure of fibrillin-2 deposition into the interdigital spaces [54,74]) and reduced limb strength [112].…”
Section: Fibrillin-2 Mutationsmentioning
confidence: 99%
“…Furthermore, positional cloning of mutant genes is now facilitated by recent progress in the field of genomics, such as exome sequencing and the availability of the mouse genome sequence. Thus, ENU mutagenesis has been used to successfully identify genes, proteins, and signaling pathways involved in a wide range of biological processes, including susceptibility to infection [40] [41], obesity [42], muscle development and function [43], cardiomyopathy [44], thrombocytopenia [45] and immunodeficiency [46]. This last report, describing a single-nucleotide mutation in the Unc93b1 gene that abrogates signaling via TLR3, 7 and 9, has largely contributed in the discovery of the human UNC93B1 mutations [14].…”
Section: Introductionmentioning
confidence: 99%